HK1098086A1 - Use of dapsone as a neuroprotector in preparing medicament for brain stroke - Google Patents

Use of dapsone as a neuroprotector in preparing medicament for brain stroke

Info

Publication number
HK1098086A1
HK1098086A1 HK07104433.0A HK07104433A HK1098086A1 HK 1098086 A1 HK1098086 A1 HK 1098086A1 HK 07104433 A HK07104433 A HK 07104433A HK 1098086 A1 HK1098086 A1 HK 1098086A1
Authority
HK
Hong Kong
Prior art keywords
dapsone
brain stroke
neuroprotector
stroke
preparing medicament
Prior art date
Application number
HK07104433.0A
Other languages
English (en)
Inventor
Castaneda Luis Camilo Rios
Martinez Marina Altagracia
Kawachi Juan Nader
Jinich Jaime Kravzov
Original Assignee
Univ Autonoma Metropolitana Pr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Autonoma Metropolitana Pr filed Critical Univ Autonoma Metropolitana Pr
Publication of HK1098086A1 publication Critical patent/HK1098086A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
HK07104433.0A 2003-07-22 2007-04-25 Use of dapsone as a neuroprotector in preparing medicament for brain stroke HK1098086A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MXPA03006549A MXPA03006549A (es) 2003-07-22 2003-07-22 Uso de la dapsona como neuroprotector en el infarto cerebral.
PCT/MX2004/000018 WO2005007239A1 (es) 2003-07-22 2004-03-16 Uso de la dapsona como neuroprotector en el infarto cerebral

Publications (1)

Publication Number Publication Date
HK1098086A1 true HK1098086A1 (en) 2007-07-13

Family

ID=34075071

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07104433.0A HK1098086A1 (en) 2003-07-22 2007-04-25 Use of dapsone as a neuroprotector in preparing medicament for brain stroke

Country Status (15)

Country Link
US (1) US8268893B2 (de)
EP (1) EP1655055B1 (de)
JP (1) JP5452844B2 (de)
CN (1) CN100500246C (de)
AT (1) ATE362783T1 (de)
BR (1) BRPI0412212A (de)
CA (1) CA2533181C (de)
DE (1) DE602004006633T2 (de)
EA (1) EA012174B1 (de)
EC (1) ECSP066316A (de)
ES (1) ES2287713T3 (de)
HK (1) HK1098086A1 (de)
MX (1) MXPA03006549A (de)
PT (1) PT1655055E (de)
WO (1) WO2005007239A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009004635A (es) * 2009-04-29 2010-10-29 Univ Autonoma Metropolitana Formas farmaceúticas solubles de la n,n´-diamino-difenilsulfona para su uso óptimo en el tratamiento de diversas enfermedades.
KR101875705B1 (ko) 2011-12-07 2018-07-06 삼성전자주식회사 디아미노디페닐술폰을 포함하는 근육 소모 관련 질환의 예방 또는 치료용 약학적 조성물
CN104177610A (zh) * 2013-05-27 2014-12-03 韩文毅 一种非线性的聚合物及其制备和用途
CN104177611A (zh) * 2013-05-27 2014-12-03 韩文毅 一种非线性的聚合物及其制备和用途
CN104069091A (zh) * 2014-07-09 2014-10-01 崔德华 氨苯砜在保护血脑屏障完整性中的应用
KR20160047318A (ko) * 2014-10-22 2016-05-02 삼성전자주식회사 다프손을 포함하는, 개체의 부위에서 혈관신생을 자극시키기 위한 조성물 및 그의 용도
KR20200107899A (ko) * 2019-11-16 2020-09-16 이종훈 알츠하이머병 혹은 뇌졸중의 뉴로인플라마섬의 치료제로서 디디에스 혹은 그 유도체

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532219A (en) * 1991-04-23 1996-07-02 The University Of British Columbia Dapsone and promin for the treatment of dementia
EE200100027A (et) * 1998-07-15 2002-06-17 Jomaa Hassan Fosfororgaanilised ühendid, neid sisaldav farmatseutiline preparaat ja nende kasutamine
GB2362101A (en) * 2000-05-12 2001-11-14 Astrazeneca Ab Treatment of chronic obstructive pulmonary disease

Also Published As

Publication number Publication date
CA2533181A1 (en) 2005-01-27
EP1655055B1 (de) 2007-05-23
CN100500246C (zh) 2009-06-17
ATE362783T1 (de) 2007-06-15
CA2533181C (en) 2012-08-07
MXPA03006549A (es) 2004-03-18
JP5452844B2 (ja) 2014-03-26
CN1852749A (zh) 2006-10-25
EA200600272A1 (ru) 2006-10-27
WO2005007239B1 (es) 2005-05-06
EA012174B1 (ru) 2009-08-28
DE602004006633D1 (de) 2007-07-05
ES2287713T3 (es) 2007-12-16
DE602004006633T2 (de) 2008-01-31
BRPI0412212A (pt) 2006-08-22
JP2006528175A (ja) 2006-12-14
PT1655055E (pt) 2007-08-31
US8268893B2 (en) 2012-09-18
WO2005007239A1 (es) 2005-01-27
US20100063159A1 (en) 2010-03-11
ECSP066316A (es) 2006-10-25
EP1655055A1 (de) 2006-05-10

Similar Documents

Publication Publication Date Title
HK1098086A1 (en) Use of dapsone as a neuroprotector in preparing medicament for brain stroke
WO2006020581A3 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
WO2004041067A3 (en) Prevention and treatment of synucleinopathic disease
WO2007012061A3 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
WO2008103472A3 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
IL176689A0 (en) Use of memantine for the preparation of a medicament for the treatment of mild and mild-to-moderate alzheimer's disease
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
PT1656346E (pt) Indole 1,2,3,4-tetrassubstituído para o tratamento de doenças respiratórias
IL177787A0 (en) 1-aminovyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease
MXPA03002209A (es) Sales del profarmaco combretastatin-a-4-fosfato con compuestos que contienen nitrogeno.
BR9814923A (pt) Método para tratamento de doença de alzheimer
WO2004110380A3 (en) Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents
PL1979521T3 (pl) Nowy sposób impregnowania powierzchni tekstylnych
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
WO2008042314A3 (en) Diagnosis and treatment of disorders of the eye
NZ546440A (en) Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
UA100994C2 (ru) Применение десмотеплазы для лечения инсульта
AU2002365288A1 (en) Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
WO2007117272A3 (en) Methods for treatment of hemorrhagic shock and related disorders
BRPI0411427A (pt) formulações de agentes antiinflamatórios não-esteróides para o tratamento de angiogênese ocular patológica
BR0308753A (pt) Método para produzir pseudo-ilhotas
SI1458376T1 (sl) Darifenacin za uporabo pri zdravljenju nuje, ki je posledica prekomerno aktivnega sečnega mehurja
WO2005013884A3 (en) Methods for preventing neurological events
WO2004006900A3 (en) Sulphydryl compounds in combination with sulphone or sulphnamide conpounds for use in microbial inflammatory diseases
HK1050480A1 (en) Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150316